184 related articles for article (PubMed ID: 31069708)
1. Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated.
Zuin M; Rigatelli G; Adami A
J Neurovirol; 2019 Aug; 25(4):439-447. PubMed ID: 31069708
[TBL] [Abstract][Full Text] [Related]
2. Risk of Stroke/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis.
Zhang Y; Luo G; Huang Y; Yu Q; Wang L; Li K
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1807-1816. PubMed ID: 28501259
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of herpes zoster and postherpetic neuralgia].
Hüning S; von Dücker L; Kohl WK; Nashan D
Hautarzt; 2019 Aug; 70(8):645-656. PubMed ID: 31270550
[TBL] [Abstract][Full Text] [Related]
4. Varicella Zoster Virus Vasculopathy After Kidney Transplantation.
Renoult E; Lanthier S; Rouleau D; Jodoin N; Letourneau-Guillon L; Pâquet M; St-Louis G; Duclos A; St-Jean L; Léveillé M; Fortin MC; Girardin C; Hébert MJ
Transplantation; 2016 Apr; 100(4):e19-20. PubMed ID: 26998852
[No Abstract] [Full Text] [Related]
5. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
Cunningham AL; Heineman T
Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
[TBL] [Abstract][Full Text] [Related]
6. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
[TBL] [Abstract][Full Text] [Related]
7. Shingrix--an adjuvanted, recombinant herpes zoster vaccine.
Med Lett Drugs Ther; 2017 Dec; 59(1535):195-196. PubMed ID: 29186082
[No Abstract] [Full Text] [Related]
8. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
Bader MS
Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
[TBL] [Abstract][Full Text] [Related]
9. Herpes Zoster Onset 9 Years After First Varicella Zoster Vaccination in an 11-year-old Child - A Case Report.
Plachouri KM; Gkentzi D; Varvarigou A; Georgiou S; Dimitriou G
Curr Pediatr Rev; 2019; 15(4):265-267. PubMed ID: 30887925
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
11. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
12. Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine.
Guo A; Lindley MC; Hurley LP; Allen JA; Allison MA; O'Leary ST; Crane LA; Brtnikova M; Beaty BL; Kempe A; Dooling KL
Vaccine; 2019 Sep; 37(37):5509-5512. PubMed ID: 31400911
[TBL] [Abstract][Full Text] [Related]
13. Shingrix for Herpes Zoster: A Review.
Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
[TBL] [Abstract][Full Text] [Related]
14. Risk of, and risk factors for, vasculopathy associated with acute herpes zoster.
Yawn BP; Lindsay AC; Yousefi M; Wang C
J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106891. PubMed ID: 36473399
[TBL] [Abstract][Full Text] [Related]
15. Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
Harbecke R; Jensen NJ; Depledge DP; Johnson GR; Ashbaugh ME; Schmid DS; Breuer J; Levin MJ; Oxman MN
Vaccine; 2020 Jan; 38(2):150-157. PubMed ID: 31679866
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of herpes zoster by vaccination].
Kofoed K; Rønholt F; Gerstoft J; Sand C
Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
[TBL] [Abstract][Full Text] [Related]
18. [How I prevent...herpes zoster by vaccination].
Nikkels AF; Piérard GE
Rev Med Liege; 2007 Jan; 62(1):44-7. PubMed ID: 17343129
[TBL] [Abstract][Full Text] [Related]
19. Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.
Schmidt SAJ; Vestergaard M; Baggesen LM; Pedersen L; Schønheyder HC; Sørensen HT
Vaccine; 2017 Oct; 35(42):5589-5596. PubMed ID: 28874322
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster: vaccination status and virtuous experiences.
Cocchio S; Gallo T; Baldo V
Minerva Med; 2020 Feb; 111(1):4-8. PubMed ID: 32286762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
